Completion date type changed
Before: Estimated. After: Actual.
Primary completion date changed
Before: Oct 2026. After: 4 Aug 2026.
Study sponsor: Celldex Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Estimated. After: Actual.
Before: Oct 2026. After: 4 Aug 2026.
Before: Estimated. After: Actual.
Before: 915 participants (planned). After: 976 participants (actual).
Before: Recruiting. After: Active not recruiting.